Thomas Beck is listed as an executive officer and director on 12 SEC Form D filings by 3 issuers between Aug 2009 and Jun 2016: Dimension Therapeutics, Inc. (Cambridge, MA — biotechnology — 2013; $65M reported sold to 12 investors), Mersana Therapeutics, Inc. (Cambridge, MA — biotechnology — 2010–2016; $33.1M reported sold to 13 investors) and Vicept Therapeutics, Inc. (Malvern, PA — pharmaceuticals — 2009–2010; $15.8M reported sold to 12 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 7 years. Across those companies the filings report $113.9M sold in total.
Listed alongside Timothy B. Lowinger (7 shared filings), David Mott (6 shared filings), Sara Nayeem (6 shared filings), Nicholas G. Bacopoulos (5 shared filings), WAYNE FOSTER (5 shared filings) and 22 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Thomas. Each name links to their own page.
1 of the issuers belongs to the sponsor group Ceptaris (2 issuers, $24.1M reported sold, 2009–2012).
What this means A sponsor group is one team that sets up a new company for each deal. Ceptaris has 2 companies on file and $24.1M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 8 bankruptcy cases matching the name listed in Key records below.
What this means 8 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 12 public filings for Thomas Beck and found 13 differences, 1 worth asking the sponsor about: Thomas Beck is no longer listed on the Feb 11, 2015 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.